NEW YORK (GenomeWeb News) — Ariosa Diagnostics said yesterday that it has received conditional approval from the New York State Department of Health to offer its Harmony non-invasive prenatal test in all pregnant women, regardless of age or risk.

Ariosa had already received approval from the NYS DOH in February to offer Harmony to women with high-risk pregnancies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.